Secondary Resistance
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory Osteosarcoma (NCT04690231) | Peking University People's Hospital | 2020-12-01 |
Track Secondary Resistance automatically
Every clearance here is in the API, with alerts when new ones post.